Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT02906787 Completed - Smoking Cessation Clinical Trials

Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain

Start date: September 13, 2016
Phase: N/A
Study type: Interventional

The purpose of this research study is to better understand (1) why people gain weight when they quit smoking and (2) whether certain types of smoking cessation (i.e. quit smoking) counseling combined with the nicotine patch help people quit smoking and gain less weight.

NCT ID: NCT02899559 Completed - Body Weight Clinical Trials

Messages and Plans to Increase Gym Utilization

Start date: September 2016
Phase: N/A
Study type: Interventional

This primary object of this study is to test to the hypothesis that the both the nudge and boost messages will increase short term gym utilization relative to the control condition but that only the boost message will increase long-term gym utilization. Non-technical summary: College students will receive one of three messages about exercise. Their card swipe data as a measure of gym utilization will be tracked as an assessment of the effect of those messages.

NCT ID: NCT02896140 Completed - Obesity Clinical Trials

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors

Start date: April 2016
Phase:
Study type: Observational

The aim of this study is to determine the relationship between the percentage of calories from dairy intake and long-term glycemic control and weight maintenance in patients with type 2 diabetes who participate in an intensive lifestyle intervention program. The investigators hypothesize that overweight and obese patients with type 2 diabetes who consume higher percentage of calories from dairy products during intensive lifestyle intervention programs have better glycemic control and maintenance of weight loss as compared to those who consume lower percentage of calories from dairy products.

NCT ID: NCT02895867 Completed - Type 2 Diabetes Clinical Trials

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes

Start date: May 2016
Phase: N/A
Study type: Interventional

This is a randomized prospective clinical study in patients with type 2 diabetes to evaluate the effect of dairy products with full or low fat on glycemic control and cardio-metabolic risk factors in comparison to a regular diet.

NCT ID: NCT02893319 Completed - Body Weight Clinical Trials

Maternal and Infant Growth Study

RIF
Start date: June 2014
Phase: N/A
Study type: Interventional

Rapid growth early in infancy is a risk factor for obesity and cardiovascular disease later in the lifespan. Evidence is limited, but both pre- and postnatal factors are associated with early rapid growth, and include high maternal BMI prior to pregnancy and excessive gestational weight gain. This research focuses on aspects of early feeding as potentially modifiable factor affecting early infant weight gain. Formula feeding mothers are randomized to receive either 5 oz of 8 oz bottles to use in feeding their infants from 2- to 16 weeks postpartum. In addition, a reference group of exclusively breastfeeding mother-infant dyads are also included. The hypothesis is that differences in feeding practices will be associated with differences in growth and that infants randomized to be fed from smaller bottles will grow more slowly that those randomized to larger bottles. Growth patterns of formula fed infants will also be compared to those of exclusively breastfed infants.

NCT ID: NCT02887950 Recruiting - Overweight Clinical Trials

Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause

Start date: September 2016
Phase: N/A
Study type: Interventional

For women aged between 55 and 65 years weight gain is a major health concern. Obesity is an important risk factor for multiple diseases (e.g. metabolic syndrome, diabetes mellitus, hypertension and cardiovascular disease), and several studies have shown that the transition to menopause is associated with adverse changes in body composition. In particular, it is common to observe the accumulation of adipose tissue in the abdominal region which is believed to be an important determinant of the increase in cardiovascular risk. The first-line strategy for weight management in overweight / obese subjects is the modification of dietary habits and lifestyle in terms of physical activity. However, nowadays, there is also a growing interest in complementary therapies (i.e. herbal supplements, acupuncture, etc ...) that can be used alone or in combination to achieve more consistent results. In this context, preliminary evidence supports the potential role of some compounds of vegetal origin such as resistant starch, epigallocatechin gallate and chlorogenic acid as adjuvants of dietary therapy for overweight. These nutrients may be an important therapeutic aid for overweight subjects. However, in support of their use, the evidence from good quality trials is limited.

NCT ID: NCT02887196 Terminated - Breast Neoplasms Clinical Trials

Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment

CARE
Start date: December 2016
Phase:
Study type: Observational

Twenty-five women will be followed through their breast cancer treatment. The women will be asked to provide their opinions and desires for lifestyle intervention at different times throughout treatment. In addition, basic clinical data will be collected . The primary goal of this pilot study is to investigate the physical and behavioral changes that occur in patients receiving treatment for breast cancer.

NCT ID: NCT02879630 Recruiting - Obesity Clinical Trials

Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity

Start date: August 2016
Phase:
Study type: Observational

Patients receiving acyclovir as standard of care will be enrolled into this study. The currently recommended dosing strategy at our institution for obese patients is to receive intravenous acyclovir dosed per an adjusted body weight [IBW + 0.4(TBW-IBW)]. They will have blood drawn once prior to the first dose of acyclovir and 10 times thereafter, over a total time period of 12 hours. These patients will already be hospitalized for other reasons, and will not be required to make additional trips to the hospital. A total of approximately 4-5 tablespoons of blood will be drawn for this study. Ten obese patients and 10 matched control (non-obese) patients will be enrolled.

NCT ID: NCT02877004 Completed - Weight Loss Clinical Trials

LLLT for Reducing Waste Circumference and Weight

LLLT
Start date: September 30, 2016
Phase: N/A
Study type: Interventional

The purpose of this research is to gather preliminary information on the effectiveness of Low Level Laser Therapy (LLLT) in helping people reduce their weight gain in the central body region.

NCT ID: NCT02867696 Terminated - Weight Loss Clinical Trials

Effect of a Technology-Based Intervention on Weight Change Post-Bariatric Surgery

Start date: January 2015
Phase: N/A
Study type: Interventional

The primary aim of this study is to examine the effect of applying a minimal contact technology-based intervention (TECH) at 1-year post-bariatric surgery on weight change compared to Standard Care. Forty participants at 1-year post bariatric surgery will be randomized to TECH or Standard Care for a period of 6 months (12 to 18 months post-surgery). Analyses will be conducted to compare these interventions for differences in body weight, body composition, fitness, physical activity, engagement, psychosocial measures, and intervention cost and cost-effectiveness of each approach. TECH will consist of a wearable monitor that provides feedback on energy expenditure and physical activity, electronic tracking of dietary intake, and integration of an electronic scale to provide comprehensive feedback to the participant on all components of weight management. TECH participants will receive a monthly telephone call from the intervention staff to provide guidance on their weight management efforts.